argenx SE
ARGX
925.70
-16.34
-1.73%
argenx SE
US · ARGX
#369 by market cap
Listed 2017
925.70
-16.34
-1.73%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
A
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 1
■ Upgrades■ Downgrades
- 1 upgrade vs 1 downgrade among tracked analyst rating changes.
- Most recent: UBS moved from Hold to Buy on 2026-08-26.
Analyst consensus 19 analysts
Buy
Avg price target 1,166.56 +26.0%
Price target rangecurrent 925.70
Low823.00
Avg1,166.56
High1,400.00
Buy 95%
Hold 5%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-28 | BofA Securities | -- | Buy | 1,157.00 |
| 2026-10-28 | Citi | -- | Buy | 1,232.00 |
| 2026-10-27 | Citi | -- | Buy | 1,232.00 |
| 2026-10-25 | Stifel | -- | Buy | 1,200.00 |
| 2026-10-23 | BofA Securities | -- | Buy | 1,157.00 |
| 2026-10-23 | Wedbush | -- | Buy | 1,130.00 |
| 2026-10-23 | Morgan Stanley | -- | Buy | 1,190.00 |
| 2026-10-23 | H.C. Wainwright | -- | Buy | 1,291.00 |
| 2026-10-23 | Oppenheimer | -- | Buy | 1,038.00 |
| 2026-10-22 | Wells Fargo | -- | Buy | 1,336.00 |
| 2026-10-22 | BofA Securities | -- | Buy | 1,157.00 |
| 2026-10-22 | Guggenheim | -- | Buy | 1,120.00 |
| 2026-10-21 | Piper Sandler | -- | Buy | 1,215.00 |
| 2026-10-21 | Citi | -- | Buy | 1,301.00 |
| 2026-10-20 | RBC Capital | -- | Buy | 1,025.00 |
| 2026-10-14 | Wells Fargo | -- | Buy | 1,356.00 |
| 2026-10-13 | BofA Securities | -- | Buy | 1,157.00 |
| 2026-10-13 | Wedbush | -- | Buy | 1,130.00 |
| 2026-10-12 | BofA Securities | -- | Buy | 1,157.00 |
| 2026-10-12 | Oppenheimer | -- | Buy | 1,038.00 |
| 2026-10-09 | Baird | -- | Hold | 823.00 |
| 2026-10-09 | Morgan Stanley | -- | Buy | 1,140.00 |
| 2026-10-09 | Evercore | -- | Buy | 1,078.00 |
| 2026-10-09 | Leerink Partners | -- | Buy | 1,115.00 |
| 2026-10-08 | Wells Fargo | -- | Buy | 1,355.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-26 | UBS | Hold → Buy | 1,400.00 |
| 2026-02-27 | Baird | Buy → Hold | 867.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-22 | -- | ±9.84% | -1.61% (in line) |
| 2026/Q2 | 2026-07-23 | -- | ±8.72% | +8.56% (in line) |
| 2026/Q1 | 2026-05-07 | -- | ±6.06% | -2.51% (in line) |
| 2025/Q4 | 2026-02-26 | -- | ±8.07% | -5.56% (in line) |
| 2025/Q3 | 2025-10-30 | -- | ±8.66% | -0.20% (in line) |
| 2025/Q2 | 2025-07-31 | -- | ±8.44% | +11.93% (beat) |
| 2025/Q1 | 2025-05-08 | -- | ±6.39% | -8.64% (beat) |
| 2024/Q4 | 2025-02-27 | -- | ±10.92% | +0.27% (in line) |
| 2024/Q3 | 2024-10-31 | -- | ±7.69% | +6.27% (in line) |
| 2024/Q2 | 2024-07-25 | -- | ±9.00% | +4.73% (in line) |
| 2024/Q1 | 2024-05-09 | -- | ±5.44% | -0.91% (in line) |
| 2023/Q4 | 2024-02-29 | -- | ±7.66% | -4.45% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
argenx SE discussion 0 comments